Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Choosing the right mix of SP 500 and total market funds depends on risk tolerance and retirement horizon. This guide helps you compare scenarios and decide wisely.
28,655 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
SpaceX is often defined by rockets and AI, but the real engine of growth sits in how it monetizes orbit-enabled infra...
A new institutional stake in Telephone and Data Systems has sparked questions about its implications. This guide expl...
Sui Group's Q1 2026 results shed light on the company’s momentum and future path. This analysis breaks down the numbe...
Palantir shares cooled in late June as investors weigh AI-led growth against valuation. Analysts remain divided, with...
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
Bitcoin climbs to a six-week peak near $74,000 as pepe explodes amid altcoin momentum. Major tokens follow, with ETH ...
As AI workloads push memory demand higher, micron stock could have substantial upside. Yet a high-capex Virginia expa...
Rivian unveiled a new entry SUV meant to broaden its addressable market, but the stock slid as investors question whe...
Analysts warn the Iran conflict could drag into 2027, worsening inflation and energy costs. This Personal Finance rep...
As AI stocks wobble after a rapid run, investors search for steadier footing. Here's this unstoppable vanguard could ...
Solana surged 13% last week, its strongest performance of 2026, driven by ETF demand and higher futures activity. Tra...